Antiviral Drugs Flashcards

1
Q

Oseltamivir

A

inhibition of influenza virus neuraminidase with the possibility of alteration of virus particle aggregation and release.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Oseltamivir trade name

A

Tamiflu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Oseltamivir treats

A

da flu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Oseltamivir side effects

A

mild nausea, abdominal discomfort, other resp. conditions should be monitored

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

oseltamivir unique properties

A

best used within the first 2 days of the infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ribavirin MOA

A

Inhibits GTP formation and viral mRNA capping; block RNA polymerases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ribavirin treats

A

broad spectrum antiviral; usually RSV, HCV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ribavirin side effects

A

transient anemia, elevated bilirubin, don’t use in pregnancy, infant resp. should be monitored

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acyclovir MOA

A

nucleoside chain terminator inhibitor of HSV DNA polymerases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Acyclovir treats

A

HSV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Acyclovir side effects

A

generally minor and well tolerated: nausea, headache, Gi, accumalates in acute renal failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

acyclovir unique properties

A

the first acyclo-nucleoside drug. activity is dependent on initial phosphorylation by viral enzyme HSV thymidine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ganciclovir MOA

A

Nucloside inhibitor of CMV DNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ganciclovir treats

A

cytomegalovirus (CMV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ganciclovir side effects

A

dose dependent neutropenia, thrombocytopenia, accumulates in renal failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ganciclovir unique properties

A

also used in combo iwth HSV-TK gene therapies as a treat termination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Foscarnet MOA

A

inhibits viral dna and rna polymerases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Foscarnet treats

A

Acyclovir resistant HSV and CMV retinitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Foscarnet side effects

A

nephrotoxicity, anemia, nausea, fever, hypocalcemia, other metal salts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

foscarnet unique properties

A

injection only, requires frequent administration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Boceprivir MOA

A

Inhibitor of hep C NS3/4A serine protease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Boceprivir treats

A

Hep C

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Boceprivir side effects

A

anemia and dysgeusia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Boceprivir usually administered with

A

ribovarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Sofosbuvir MOA
inhibitor of Hep C RNA polymerase
26
Sofosburvir treats
Hep C
27
Sofosburvir side effects
fatigue, rash, headache, nausea, maybe contraindicted with anti-arrythmic medicines
28
Sofosburvir unique properties
probably acts like a chain terminator but still has 3 OH intact
29
Entecavir MOA
inhibitor of Hep B reverse transcriptase
30
Entecavir treats
Hep B
31
Entecavir side effects
fatigue, rash, headache, nausea, not to be used with drugs causing renal toxicity
32
entecavir unique properties
used in lamivudine resistant HBV strains
33
Zidovudine MOA
nucleoside chain terminator inhibitor of HIV reverse transcriptase (NRTI)
34
zidovudine treats
HIV
35
Zidovudine side affects
anemia, granulocytopenia, neutropenia, headache, nausea, myalgias, neurtoxicity (can lead to seizures), lactic acidosis, steatosis
36
zidovudine unique properties
first approved HIV drug
37
Efavirenz MOA
non nucleoside inhibitor of HIV reverse transcriptase (NNRTI)
38
Efavirenz treats
HIV
39
Efavirenz side effects
rash(stevens johnson rash), dizziness, headache, loss of focus, vivid dreams, P450 inhibitor, side effects common but usually resolve
40
Raltegravir MOA
strand transfer inhibitor of HIV integrase
41
raltegravir treats
HIV
42
raltegravir side effects
headache, fatigue, insomnia, n/d, elevated creatine kinase with rhabdomyolysis, possible depression with suicidal ideation
43
raltegravir unique properties
usually well tolerated, useful in both naive and treatment experienced subjects
44
Dolutegravir MOA
strand transfer inhibitor of HIV integrase
45
dolutegravir treats
HIV
46
dolutegravir side effects
headache, fatigue, insomnia, n/d, jaundice, do not use with antacids
47
dolutegravir unique properties
has limited cross-resistance profiles with other integrase inhibitors
48
Ritonavir MOA
inhibitor of HIV protease
49
Ritonavir treats
used to boost efficacy of other HIV protease inhibitors
50
ritonavir side effects
signigicant gi intolerance, headache, fatigue, diarrhea, perioral paresthesia, hepatitis, increased lipids, taste perversion,
51
ritonavir drug interactions
statins, acid-reducing drugs
52
ritonavir unique properties
a potent inhibitor of p450 3A
53
newer version of ritonavir
Cobicistat
54
Lopinavir MOA
inhibitor of HIV protease
55
Lopinavir treats
HIV
56
Lopinavir side effects
significant GI intolerance, hyper triglyceridemia
57
lopinavir drug interactions
statins and acid reducing drugs
58
Atazanavir MOA
inhibitor of HIV protease
59
Atazanavir treats
HIV
60
Atazanavir side effects
GI intolerance, jaundice, nephrolithiasis, increased glucose
61
atazanavir drug interactions
statins
62
atazanavir unique properties
more tolerated in regard to gi side effects less hylerlipidemia